B12 deficiency and acid suppression
If your patient is on long-term acid-suppression therapy with a proton pump inhibitor (PPI) or histamine 2 (H2) blocker, be concerned about vitamin B12 deficiency. That is the message from a new study by Kaiser Permanente. Chronic use of acid-suppressing medications is common with hundreds of millions of prescriptions written every year as well as widespread over-the-counter use. The researchers found that among patients diagnosed with B12 deficiency, 12% were dispensed ≥ 2 year’s supply of a PPI, and 4.2% were dispensed ≥ 1 year’s supply or more of an H2 antagonist, which was significantly higher than the rate of patients without B12 deficiency (odds ratio [OR] of B12 deficiency with PPI 1.65 95% confidence interval (CI), 1.58-1.73); OR of B12 deficiency with H2 blocker 1.25 (95% CI, 1.17-1.34). The authors conclude that previous and current gastric acid suppression was significantly associated with the presence of B12 deficiency (JAMA 2013;310:2435-2442). Vitamin B12 deficiency is probably more common than we think and the long-term effects can be devastating. It is good to keep this in mind for patients on chronic acid-suppressing medications.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.